Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Financing Activities (2016 - 2026)

Rockwell Medical filings provide 16 years of Cash from Financing Activities readings, the most recent being -$1.1 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 137.93% to -$1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 42.13% decrease, with the full-year FY2025 number at $4.3 million, down 42.13% from a year prior.
  • Cash from Financing Activities hit -$1.1 million in Q4 2025 for Rockwell Medical, down from $6.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $26.8 million in Q2 2022 to a low of -$6.0 million in Q4 2022.
  • Median Cash from Financing Activities over the past 5 years was -$549000.0 (2021), compared with a mean of $1.9 million.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 162300.0% in 2021 and later skyrocketed 447150.0% in 2022.
  • Rockwell Medical's Cash from Financing Activities stood at -$1.6 million in 2021, then plummeted by 268.47% to -$6.0 million in 2022, then skyrocketed by 87.6% to -$742000.0 in 2023, then soared by 476.28% to $2.8 million in 2024, then plummeted by 137.93% to -$1.1 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$1.1 million (Q4 2025), $6.7 million (Q3 2025), and -$650000.0 (Q2 2025) per Business Quant data.